Get started
Author

Paola Pozzi

Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa
2008 · Paolo Pedrazzoli, Antonio Farris, et al. · Journal of Clinical Oncology · 168
PDF
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A.1
1999 · E Bajetta, N Zilembo, et al. · European Journal of Cancer · 69
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism
2002 · E. Bajetta, A. Martinetti, et al. · Annals of Oncology · 45
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
2000 · E. Bajetta, N. Zilembo, et al. · Annals of Oncology · 36
PDF
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial
2000 · Emilio Bajetta, Simonetta Chiara Stani, et al. · Cancer · 30
PDF
Steroidal aromatase inhibitors in elderly patients
2000 · Emilio Bajetta, Nicoletta Zilembo, et al. · Critical Reviews in Oncology/Hematology · 16
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.
2003 · Antonia Martinetti, Nicoletta Zilembo, et al. · PubMed · 13
Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients
2002 · L. Ferrari, A. Martinetti, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 10
The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers
2000 · Antonia Martinetti, Leonardo Ferrari, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 9
Fluoropyrimidines in the Treatment of Advanced Neoplastic Diseases: Role and Advantages of UFT
1999 · Michele Del Vecchio, Giuseppe Procopio, et al. · Tumori Journal · 8
Front line chemotherapy with four different schedules of gemcitabine and carboplatin in stage IV non-small cell lung cancer (NSCLC)
2001 · S.C. Stani, E. Bajetta, et al. · European Journal of Cancer · 4
Markers of bone turnover in metastatic breast cancer (MBC) patients having progressed on tamoxifen: Short term effect of further treatment with either exemestane (EXE) or megestrol acetate (MA)
2001 · N. Zilembo, E. Bajetta, et al. · European Journal of Cancer · 2
Biological study of anastrozole in post-menopausal advanced breast cancer (ABC) patients: Effects on bone metabolism and oestrogen suppression
2001 · A. Martinetti, E. Bajetta, et al. · European Journal of Cancer · 1
The Effects of a Modified Mediterranean Diet on Gut Microbiota and Chemotherapy Side Effects in Patients With Metastatic Colorectal Cancer Undergoing First-Line Chemotherapy With or Without Either Antiepidermal Growth Factor Receptor or Antivascular Endothelial Growth Factor Agent: Protocol for a Randomized Pilot Study in Italy
2025 · Salvatore Artale, Francesca Filiali, et al. · JMIR Research Protocols
c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients
2002 · N. Zilembo, L. Mariani, et al. · The Breast
Works count: 16
Citation count: 411
H-index: 9
I10-index: 8
Year
Topic
Type